After warning letter, Whoop and FDA in discussions about controversial blood pressure feature
Wearable maker Whoop has not resolved its dispute with the FDA over a blood pressure feature launched last year. The FDA warned Whoop in July 2025 that the feature requires regulatory review as a medical device, though Whoop argues it qualifies as a wellness product exempt from FDA oversight.